Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection

S Keam, D Megawati, SK Patel, R Tiwari… - Reviews in Medical …, 2020 - Wiley Online Library
The outbreak of coronavirus disease 2019 (COVID‐19) and pandemic, caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a major concern …

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

D Darif, I Hammi, A Kihel, IEI Saik, F Guessous… - Microbial …, 2021 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 …

[HTML][HTML] Isolation, sequence, infectivity, and replication kinetics of severe acute respiratory syndrome coronavirus 2

A Banerjee, JA Nasir, P Budylowski, L Yip… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Since its emergence in Wuhan, China, in December 2019, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has infected≈ 6 million persons worldwide. As …

T cell responses to whole SARS coronavirus in humans

CK Li, H Wu, H Yan, S Ma, L Wang… - The Journal of …, 2008 - journals.aai.org
Effective vaccines should confer long-term protection against future outbreaks of severe
acute respiratory syndrome (SARS) caused by a novel zoonotic coronavirus (SARS-CoV) …

[HTML][HTML] Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

Z He, C Zhao, Q Dong, H Zhuang, S Song… - International journal of …, 2005 - Elsevier
INTRODUCTION: Severe acute respiratory syndrome (SARS) caused large outbreaks of
atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China …

Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential …

A Jafarzadeh, P Chauhan, B Saha, S Jafarzadeh… - Life sciences, 2020 - Elsevier
Abstract The COVID-19-, SARS-and MERS-related coronaviruses share many genomic and
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …

Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID‐19 patients: Clinical and laboratory characteristics

S Taghiloo, M Aliyali, S Abedi… - Journal of medical …, 2021 - Wiley Online Library
A novel member of human coronavirus, named severe acute respiratory syndrome
coronavirus‐2 (SARS‐CoV‐2), has been recently recognized in China and rapidly spread …

Neutralizing antibody-dependent and-independent immune responses against SARS-CoV-2 in cynomolgus macaques

H Ishigaki, M Nakayama, Y Kitagawa, CT Nguyen… - Virology, 2021 - Elsevier
We examined the pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) in cynomolgus macaques for 28 days to establish an animal model of COVID-19 for …

Cytokines and COVID-19: friends or foes?

M Rokni, MR Hamblin, N Rezaei - Human vaccines & …, 2020 - Taylor & Francis
The cytokine storm following sepsis has been proven to be an important mechanism for
triggering acute respiratory distress syndrome, which is a fatal uncontrolled systemic …

SARS‐CoV‐2‐reactive interferon‐γ‐producing CD8+ T cells in patients hospitalized with coronavirus disease 2019

E Gimenez, E Albert, I Torres… - Journal of medical …, 2021 - Wiley Online Library
There is limited information on severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) T‐cell immune responses in patients with coronavirus disease 2019 (COVID‐19) …